A Randomised, Double-Blinded, Double-Dummy, Placebo-Controlled, MultiCentre-, Six-Way, Crossover Study to Assess the Pharmacodynamics, Pharmacokinetics, and Safety of Abediterol Single Dose, Given by Dry Powder Inhaler (DPI) or Pressurised Metered-Dose Inhaler (pMDI), in Patients With Asthma on Inhaled Corticosteroids
Phase of Trial: Phase I
Latest Information Update: 23 Dec 2016
At a glance
- Drugs Abediterol (Primary) ; Abediterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 19 Dec 2016 Status changed from active, no longer recruiting to completed.
- 22 Sep 2016 Planned End Date changed from 1 Nov 2016 to 1 Oct 2016.
- 22 Sep 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Oct 2016.